Newsroom
-
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
Business WireLearn More -
Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
Business WireLearn More -
AAV Delivered NanoCas CRISPR System Edits Muscle in Non-Human Primates
Genetic Engineering & Biotechnology NewsLearn More -
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
Business WireLearn More -
California Life Sciences Announces Winners of 21st Annual Pantheon Awards
California Life SciencesLearn More -
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Business WireLearn More -
Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy
Learn More -
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Learn More -